From gastroprotective to ulcerogenic effects of glucocorticoids: Role of long-term glucocorticoid action

Current Pharmaceutical Design

Volumn 20, Issue 7, 2014, Pages 1045-1050

  Filaretova, Ludmila ^a   Podvigina, Tatiana ^a   Bagaeva, Tatiana ^a   Morozova, Olga ^a  

^a PAVLOV INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Dexamethasone; Gastric mucosa; Gastroprotection; Glucocorticoids; Indomethacin; Injury; Stress; The hypothalamic pituitary adrenocortical axis

Indexed keywords

GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; STOMACH MUCOSA; STOMACH ULCER; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTRIC MUCOSA; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; STOMACH ULCER; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84895152927     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990419     Document Type: Article

References (55)

1. Luo JC, Chang FY, Chen TS, et al. Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy. Br J Clin Pharmacol 2009; 68: 252-9.
2. Olsen M, Christensen S, Riis A, Thomsen RW. Preadmission use of systemic glucocorticoids and 30-day mortality following bleeding peptic ulcer: a population-based cohort study. Am J Ther 2010; 17: 23-29.
3. Black HE. The effects of steroids upon the gastrointestinaltract. Toxicol Pathol 1988; 16: 213-22.
4. Bandyopadhyay U, Biswas K, Bandyopadhyay D, Ganguly CK, Banerjee RK. Dexamethasone makes the gastric mucosa susceptible to ulceration by inhibiting prostaglandin synthetase and peroxidase-two important gastroprotective enzymes. Mol Cell Biochem 1999; 202: 31-6.
5. Takeuchi Y, Takahashi M, Fuchikami J. Vulnerability of gastric mucosa to prednisolone in rats chronically exposed to cigarette smoke. J Pharmacol Sci 2008; 106: 585-92.
6. Peskar BM, Ehrlich K, Schuligoi R, Peskar BA. Role of lipoxygenases and lipoxin A(4)/annexin-1 receptor in gastric protection induced by 20% ethanol or sodium salicylate in rats. Pharmacology 2009; 84(5): 310-3.
7. Derelanko M J, Long J F. Influence of prednisolone on ethanolinduced gastric injury in the rat. Dig Dis Sci 1982; 27: 149-54.
8. McCafferty DM, Granger DN, Wallace JL. Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenterology 1995; 109: 1173-80.
9. Souza MH, Lemos HP, Olivera RB, Cunha FQ. Gastric damage and granulocyte infiltration induced by indomethacin in tumer necrosis factor receptor (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice. Gut 2004; 53: 791-96.
10. Takeuchi K, Nishiwaki H, Okada M, Niida H, Okabe S. Bilateral adrenalectomy worsens gastric mucosal lesions induced by indomethacin in the rat. Role of enhanced gastric motility. Gastroenterology 1989; 97: 284-93.
11. Hernandez DE, Adcock JW, Nemeroff CB, Prange AJ. The role of adrenal gland in cytoprotection against stress-induced gastric ulcers in rats. J Neurosci Res 1984; 11: 193-201.
12. Szabo S, Callagher GT, Horner HC, et al. Role of the adrenal cortex in gastric mucosal protection by prostaglandins, sulfhydryls, and cimetidine in the rat. Gastroenterology 1983; 85: 1384-90.
13. Perretti M, Mugridge KG, Wallace JL, Parénte L. Reduction of aspirin-induced gastric damage in rats by interleukin-1 beta: possible involvement of endogenous corticosteroids. J Pharmacol Exp Ther 1992; 261: 1238-47.
14. Weiss JM. Effects of coping behavior in different warning signal conditions on stress pathology in rats. J Comp Physiol Psychol 1971; 77: 1-13.
15. Murphy HM, Wideman CH, Brown TS. Plasma corticosterone levels and ulcer formation in rats with hippocampal lesions. Neuroendocrinology 1979; 28: 123-30.
16. Murison R, Overmier JB, Hellhammer DH, Carmona M. Hypothalamo-pituitary-adrenal manipulations and stress ulcerations in rats. Psychoneuroendocrinology 1989; 14: 331-8.
17. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984; 5: 25-44.
18. Filaretova L. The dependence of the formation of stress gastric ulcers on the function of hypothalamo-hypophyseal-adrenocortical system. Fiziol Zh SSSR Im I M Sechenova 1990; 76: 1594-600.
19. Filaretova LP, Filaretov AA. The effect of large corticosteroid doses on stomach ulceration: a new hypothesis. Fiziol Zh SSSR Im I M Sechenova 1992; 78: 77-83.
20. Filaretova LP. Gastric stress ulcers: the protective role of hormones of the hypothalamo-hypophyseal-adrenocortical system. Fiziol Zh Im I M Sechenova 1995; 81: 50-60.
21. Filaretova LP, Filaretov A, Makara GB. Corticosterone increase inhibits stress-induced gastric erosions in rats. Am J Physiol 1998; 274: G1024-30.
22. Filaretova L, Bagaeva T, Podvigina T, Makara G. Various ulcerogenic stimuli are potentiated by glucocorticoid deficiency in rats. J Physiol Paris 2001; 95: 59-65.
23. Filaretova LP, Bagaeva TR, Makara GB. Aggravation of nonsteroidal antiinflammatory drug gastropathy by glucocorticoid deficiency or blockade of glucocorticoid receptor in rats. Life Sci 2002; 71: 2457-68.
24. Filaretova LP, Podvigina TT, Bagaeva TR, Tanaka A, Takeuchi K. Gastroprotective action of glucocorticoid hormones during NSAID treatment. Inflammopharmacology 2005; 13: 27-43.
25. Filaretova LP. The hypothalamic-pituitary-adrenocortical system: hormonal brain-gut interaction and gastroprotection. Autonomic Neurosci: Basic and Clinical 2006; 125: 86-93.
26. Filaretova L, Podvigina T, Bobryshev P, Bagaeva T, Tanaka A, Takeuchi K. Hypothalamic-pituitary-adrenocortical axis: the hidden gold in gastric mucosal homeostasis. Inflammopharmacology 2006; 14: 207-13.
27. Filaretova L, Bagaeva T, Amagase K, Takeuchi K. Contribution of glucocorticoids to protective influence of preconditioning mild stress against stress-induced gastric erosions. Ann N Y Acad Sci 2008; 1148: 209-12.
28. Filaretova L. Gastroprotective role of glucocorticoids during NSAID-induced gastropathy. Curr Pharm Des 2013; 19: 29-33.
29. Moguilewski M, Philibert D. RU 38486: potent antiglucocorticoid activity correlated with strong binding to cytosolic glucocorticoid receptor followed by an impaired activation. J Steroid Biochem 1984; 20: 271-6.
30. Tanaka A, Hatazawa R, Takahira Y, Izumi N, Filaretova L, Takeuchi K. Preconditioning stress prevents cold restraint stress-induced gastric lesions in rats: roles of COX-1, COX-2, and PLA2. Dig Dis Sci 2007; 52: 478-87.
31. Filaretova L, Podvigina T, Bagaeva T, Makara G. Gastroprotective action of glucocorticoids during the formation and the healing of indomethacin-induced gastric erosions in rats. J Physiol Paris 2001; 95: 201-8.
32. Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000; 119: 521-35.
33. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000-16.
34. Holzer P. Neural emergency system in the stomach. Gastroenterology 1998; 114(4): 823-39.
35. Mózsik G, Szabó IL, Czimmer J. Approaches to gastrointestinal cytoprotection: from isolated cells, via animal experiments to healthy human subjects and patients with different gastrointestinal disorders. Curr Pharm Des 2011; 17: 1556-72.
36. Szlachcic A, Krzysiek-Maczka G, Pajdo R, et al. The impact of asymmetric dimethylarginine (ADAMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage. Curr Pharm Des 2013;19: 90-7.
37. Bobryshev PYu, Bagaeva TR, Podvigina TT, Filaretova L. Gastroprotective action of glucocorticoid hormones in rats with desensitization of capsaicin-sensitive sensory neurons. Inflammopharmacology 2005; 13: 217-28.
38. Filaretova L, Bobryshev P, Bagaeva T, Podvigina T, Takeuchi K. Compensatory gastroprotective role of glucocorticoid hormones during inhibition of prostaglandin and nitric oxide production and desensitization of capsaicin-sensitive sensory neurons. Inflammopharmacology 2007; 5: 146-53.
39. Whittle BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rats. Br J Pharmacol 1990; 99: 606-11.
40. Filaretova LP, Maltcev AN, Bogdanov AI, Levkovich YuI. Role of gastric microcirculation in the gastroprotection by glucocorticoids released during water-restraint stress in rats. Chin J Physiol 1999; 42: 145-52.
41. Filaretova L, Tanaka A, Miyazawa T, Kato S, Takeuchi K. Mechanisms by which endogenous glucocorticoids protects against indo methacin-induced gastric injury in rats. Am J Physiol 2002; 283: G1082-89.
42. Filaretova LP, Podvigina TT, Bagaeva TR, Tanaka A, Takeuchi K. Mechanisms underlying gastroprotective action of glucocorticoids released in response to ulcerogenic stress factors. Ann NY Acad Sci 2004; 1018: 288-93.
43. Chan O, Chan S, Inouye K, Shum K, Matthews SG, Vranic M. Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses. Diabetes 2002; 51: 1681-9.
44. Subramanian S, Trence DL. Immunosuppressive agents: effects on glucose and lipid metabolism. Endocrinol Metab Clin North Am 2007; 36: 891-905.
45. Weidenfeld J, Corcos AP, Wohlman A, Feldman S. Characterization of the 2-deoxyglucose effect on the adrenocortical axis. Endocrinology 1994; 134: 1924-31.
46. Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab 1998; 83: 2350-54.
47. Takeuchi K, Okada M, Niida H, Okabe S. Possible mechanisms involved in gastric hypermotility induced by indomethacin in the rat: Role of glycoprivic response. Dig Dis Sci 1990; 35: 984-92.
48. Filep JG, Hermán F, Földes-Filep E, Schneider F, Braquet P. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor. Br J Pharmacol 1992; 105: 912-8.
49. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 2008; 135: 41-60.
50. Sikiric P, Seiwerth S, Rucman R, et al. Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157. Curr Pharm Des 2013; 19: 76-83.
51. Szabó IL, Czimmer J, Szolcsányi J, Mózsik G. Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects. Curr Pharm Des 2013; 19: 84-9.
52. Filaretova L, Podvigina T, Bagaeva T, Morozova O. Dual action of glucocorticoid hormones on the gastric mucosa: how the gastroprotective action can be transformed to the ulcerogenic one. In flammopharmacology 2009; 17: 15-22.
53. Filaretova L, Morozova O, Bagaeva T, Podvigina T. From gastroprotective to proulcerogenic action of glucocorticoids on the gastric mucosa. J Physiol Pharmacol 2009; 60(Suppl 7): 79-86.
54. Sandweiss DJ. Effects of adrenocorticotropic hormone (ACTH) and of cortisone on peptic ulcer. I. Clinical review. Gastroenterology 1954; 27: 604-16.
55. Longui CA. Glucocorticoid therapy: minimizing side effects. J Pediatr (Rio J) 2007; 83 (Suppl. 5): S163-S77.